~~<i id='A33135DA08'><strike id='A33135DA08'><tt id='A33135DA08'><pre id='A33135DA08'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

leisure time

explore

author：comprehensive 2025-09-28 11:48:55 - browse：4

An illustration of red blood cells — Adobe

As a boy growing up with hemophilia A, Noah Frederick reserved the end of his annual checkups to talk about new technologies. His doctor walked through various experimental approaches for the bleeding disorder and, invariably, gene therapy. It was coming, he always said, in your lifetime.

Last year, it finally arrived. But Frederick, now a 23-year-old software engineer, isn’t sure he’ll get it. He wants to be part of the sci-fi future gene therapy has always represented, but a recent doctor’s visit left him uncertain.

“I’m on the fence,” he said.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Moonlake's readout produced a cash windfall. Risks remain
Next article： Congress must reauthorize a committee to support older Americans

hotspot

Wikipedia

focus

F.A.Murphy/CDCVirBiotechnologysaidThursdaythatalong-actingantibodydrugdesignedtoprotecthealthyindivi

WSS

Senate committee advances SCOTUS ethics bill after alleged justice misconduct

DeSantis talks Trump, trans issues and 'what wokeness is'

Congress must reauthorize a committee to support older Americans

Ending racial health disparities hinges on penalties, political will

Readout Newsletter: The latest at Gilead, Catalent, and the NIH

Gain of function research would be limited under House proposal

leisure time

explore

hotspot

Trump demands the U.S. pay no more for drugs than other countries … again

Gain of function research would be limited under House proposal

Drug repurposing or repositioning? The language matters

Readout Newsletter: Bayer's future, Merck Caraway acquisition, etc

Dobbs anniversary: the lost opportunity of abortion as health care

Readout Newsletter: Bayer's future, Merck Caraway acquisition, etc

Apple is now the first public company to be valued at $3 trillion

Ransomware attacks on hospitals: Study outlines patient impact

Guidelines to prevent youth baseball injuries need more muscle

Weight loss drug Wegovy cuts risk of heart attacks in milestone trial

hotspot

PBM reforms clear House panel

Indian pharmaceutical industry in denial over drug

Tesla recalling nearly 16,000 of its 2021

Ending racial health disparities hinges on penalties, political will

Tocagen's brain cancer gene therapy trial continues. Investors worry

Hospitals look to new technology to keep health care workers safe

hotspot

Wikipedia

focus

focus